These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38064237)

  • 1. Plasma cytokines profile in patients with Alzheimer's and Parkinson's Disease: a comparative study in terms of inflammation.
    Shateri S; Khatami SH; Haghbin Toutounchi A; Rajaei S; Mahdavi M; Mahmoodi Baram S; Shahidi GA; Habibi AH; Aghamollaii V; Ghlichnia B; Safakish L; Doagoo A; Salmani F; Tafakhori A; Keramatinia A; Shahmohammadi MR; Karima S
    Int J Neurosci; 2023 Dec; ():1-10. PubMed ID: 38064237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease.
    Diaz K; Kohut ML; Russell DW; Stegemöller EL
    Brain Behav Immun Health; 2022 May; 21():100442. PubMed ID: 35308082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.
    King E; O'Brien J; Donaghy P; Williams-Gray CH; Lawson RA; Morris CM; Barnett N; Olsen K; Martin-Ruiz C; Burn D; Yarnall AJ; Taylor JP; Duncan G; Khoo TK; Thomas A
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1244-1250. PubMed ID: 30993722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
    Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
    J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Cytokines Profile in Subjects with Alzheimer's Disease: Interleukin 1 Alpha as a Candidate for Target Therapy.
    Mahdavi M; Karima S; Rajaei S; Aghamolaii V; Ghahremani H; Ataei R; Tehrani HS; Baram SM; Tafakhori A; Safarpour Lima B; Shateri S; Fatemi H; Mokhtari F; Nikzameer A; Yarhosseini A; Gorji A
    Galen Med J; 2021; 10():e1974. PubMed ID: 35434157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.
    Perea RD; Rada RC; Wilson J; Vidoni1 ED; Morris JK; Lyons KE; Pahwa R; Burns JM; Honea RA
    J Alzheimers Dis Parkinsonism; 2013 Aug; 3():123. PubMed ID: 24724042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.
    Alam Q; Alam MZ; Mushtaq G; Damanhouri GA; Rasool M; Kamal MA; Haque A
    Curr Pharm Des; 2016; 22(5):541-8. PubMed ID: 26601965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship.
    Nishal S; Phaugat P; Bazaad J; Dhaka R; Khatkar S; Khatkar A; Khayatkashani M; Alizadeh P; Haghighi SM; Mehri M; Kashani HRK
    CNS Neurol Disord Drug Targets; 2023; 22(7):1057-1069. PubMed ID: 35702799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary levels of disease-related biomarkers in the early stages of Parkinson's and Alzheimer's disease:
    Sabaei M; Rahimian S; Haj Mohamad Ebrahim Ketabforoush A; Rasoolijazi H; Zamani B; Hajiakhoundi F; Soleimani M; Shahidi G; Faramarzi M
    IBRO Neurosci Rep; 2023 Jun; 14():285-292. PubMed ID: 36942319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Koca S; Kiris I; Sahin S; Cinar N; Karsidag S; Hanagasi HA; Yildiz GB; Tarik Baykal A
    Neurosci Lett; 2022 Aug; 786():136799. PubMed ID: 35842208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.
    Liu T; Zuo H; Ma D; Song D; Zhao Y; Cheng O
    J Neuroinflammation; 2023 Jul; 20(1):167. PubMed ID: 37475029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
    Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
    Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.
    Lim NS; Swanson CR; Cherng HR; Unger TL; Xie SX; Weintraub D; Marek K; Stern MB; Siderowf A; ; ; Trojanowski JQ; Chen-Plotkin AS
    Ann Clin Transl Neurol; 2016 May; 3(5):346-55. PubMed ID: 27231704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
    Mizutani Y; Ohdake R; Tatebe H; Higashi A; Shima S; Ueda A; Ito M; Tokuda T; Watanabe H
    J Neurol; 2023 Nov; 270(11):5461-5474. PubMed ID: 37480401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function.
    Chan L; Chung CC; Chen JH; Yu RC; Hong CT
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease.
    Zhang H; Wu J; Shen FF; Yuan YS; Li X; Ji P; Zhu L; Sun L; Ding J; Niu Q; Zhang KZ
    CNS Neurosci Ther; 2020 May; 26(5):518-526. PubMed ID: 31828965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1β and TNF-α play an important role in modulating the risk of periodontitis and Alzheimer's disease.
    Wang RP; Huang J; Chan KWY; Leung WK; Goto T; Ho YS; Chang RC
    J Neuroinflammation; 2023 Mar; 20(1):71. PubMed ID: 36915108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.